Table of Contents
ISRN Molecular Biology
Volume 2013 (2013), Article ID 451298, 4 pages
http://dx.doi.org/10.1155/2013/451298
Research Article

Efficient IDUA Gene Mutation Detection with Combined Use of dHPLC and Dried Blood Samples

1Departamento de Genética Humana, Unidade I&D-P DLS, CGMJM, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA, IP), Pr. Pedro Nunes 88, 4099-028 Porto, Portugal
2Departamento de Genética Humana, Unidade de Tecnologia e Inovação (UTI), Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA, IP), Avenida Padre Cruz, 1649-016 Lisboa, Portugal

Received 14 March 2013; Accepted 3 April 2013

Academic Editors: D. Bozon, E. Caffarelli, A. D. Hollenbach, B. L. Nielsen, and C.-H. Yuh

Copyright © 2013 Diogo Ribeiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. F. Neufeld and J. Muenzer, “The mucopolysaccharidoses,” in The Metabolic and Molecular Bases of Inherited Disease, C. R. Scriver, A. Beaudet, W. S. Sly, and D. Valle, Eds., pp. 3421–3452, McGraw-Hill, New York, NY, USA, 8th edition, 2001. View at Google Scholar
  2. H. S. Scott, L. J. Ashton, H. J. Eyre et al., “Chromosomal localization of the human α-L-iduronidase gene (IDUA) to 4p16.3,” The American Journal of Human Genetics, vol. 47, no. 5, pp. 802–807, 1990. View at Google Scholar · View at Scopus
  3. H. S. Scott, D. S. Anson, A. M. Orsborn et al., “Human alpha-l-iduronidase: cDNA isolation and expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 21, pp. 9695–9699, 1991. View at Publisher · View at Google Scholar
  4. H. S. Scott, X. H. Guo, J. J. Hopwood, and C. P. Morris, “Structure and sequence of the human α-L-iduronidase gene,” Genomics, vol. 13, no. 4, pp. 1311–1313, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. Terlato and G. F. Cox, “Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature,” Genetics in Medicine, vol. 5, no. 4, pp. 286–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Matte, G. Yogalingam, D. Brooks et al., “Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients,” Molecular Genetics and Metabolism, vol. 78, no. 1, pp. 37–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Pinto, C. Caseiro, M. Lemos et al., “Prevalence of lysosomal storage diseases in Portugal,” European Journal of Human Genetics, vol. 12, no. 2, pp. 87–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Xiao and P. J. Oefner, “Denaturing high-performance liquid chromatography: a review,” Human Mutation, vol. 17, no. 6, pp. 439–474, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Kasper, F. Iqbal, L. Dvorakova et al., “Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-l-iduronidase mutations causing mucopolysaccharidosis type I,” Clinica Chimica Acta, vol. 411, no. 5-6, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Reuser, F. W. Verheijen, D. Bali et al., “The use of dried blood spot samples in the diagnosis of lysosomal storage disorders—current status and perspectives,” Molecular Genetics and Metabolism, vol. 104, no. 1-2, pp. 144–148, 2011. View at Publisher · View at Google Scholar
  11. N. A. Chamoles, M. B. Blanco, D. Gaggioli, and C. Casentini, “Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper,” Clinical Chemistry, vol. 47, no. 12, pp. 2098–2102, 2001. View at Google Scholar · View at Scopus
  12. P. Carbonell, M. C. Turpin, D. Torres-Moreno et al., “Comparison of allelic discrimination by dHPLC, HRM, and Taqman in the detection of braf mutation V600E,” Journal of Molecular Diagnostics, vol. 13, no. 5, pp. 467–473, 2011. View at Publisher · View at Google Scholar
  13. H. Takashima, C. F. Boerkoel, and J. R. Lupski, “Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy,” Genetics in Medicine, vol. 3, no. 5, pp. 335–342, 2001. View at Google Scholar · View at Scopus
  14. E. B. de Oliveira-Junior, C. Prando, J. A. Lopez et al., “High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost-effective method for screening molecular defects: four novel mutations found in x-linked chronic granulomatous disease,” Scandinavian Journal of Immunology, vol. 76, no. 2, pp. 158–166, 2012. View at Publisher · View at Google Scholar